Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin vs Tamsulosin for Stone Clearance After ESWL
NCT01560091Phase 3Withdrawn
- Sponsor
- Einstein Healthcare Network
- Start
- Mar 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of silodosin in nephrolithiasis, sponsored by Einstein Healthcare Network. Planned start Mar 2012; status: withdrawn.
02
Drugs
silodosin
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT01560091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01560091.